These effects, together with a past report exhibiting that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,two help the strategy of concentrating on ACKR3 as a novel way to modulate the opioid program, which could open up new therapeutic avenues for opioid-associa